North America Epigenetics Market

The report "North America Epigenetics Market by Product & Service [Enzymes, Kits & Reagents (Antibodies), Software], Method [DNA Methylation, Histone Modification], Technique [NGS, PCR], Application [Oncology, Immunology, Developmental Biology]-Forecast to 2030" is projected to grow from USD 0.93 billion in 2025 and to reach USD 1.78 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 13.8% during the forecast period.

Browse 350 market data Tables and 45 Figures spread through 300 Pages and in-depth TOC on "North America Epigenetics Market by Product & Service [Enzymes, Kits & Reagents (Antibodies), Software], Method [DNA Methylation, Histone Modification], Technique [NGS, PCR], Application [Oncology, Immunology, Developmental Biology]-Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/north-america-epigenetics-market-8695913.html

North America’s epigenetics market is expanding due to a strong focus on precision oncology and rising biomarker-led drug development activity. High R&D intensity across biopharma, academia, and CROs is sustaining high study volumes and repeat testing. Wider adoption of single-cell and multi-omics technologies is increasing the need for deeper epigenomic profiling. Growing interest in methylation signatures for liquid biopsy is accelerating clinical relevance. Investments in data infrastructure and standardized workflows are also improving scalability.

North America’s epigenetics market is expanding due to a strong focus on precision oncology and rising biomarker-led drug development activity. High R&D intensity across biopharma, academia, and CROs is sustaining high study volumes and repeat testing. Wider adoption of single-cell and multi-omics technologies is increasing the need for deeper epigenomic profiling. Growing interest in methylation signatures for liquid biopsy is accelerating clinical relevance. Investments in data infrastructure and standardized workflows are also improving scalability.

The services segment is expected to grow at the fastest rate during the forecast period.

On the basis of offering, the epigenetics market in North America is divided into products and services. The services segment is expected to grow fastest during the forecast period, as many end users prefer outsourcing to reduce capex and shorten project timelines. CROs and specialized labs are expanding capacity for epigenetic profiling, assay development, and data interpretation. This is especially relevant for multi-site studies and large cohorts that require high throughput. Demand is also rising for integrated sample-to-insight delivery, including analytics and reporting.

The next-generation sequencing (NGS) segment dominated the market in 2024.

By technology, the market has been segmented into NGS, PCR & QPCR, mass spectrometry, sonication, and other technologies. The next-generation sequencing (NGS) segment held the largest share in 2024, due to its scalability and high information content across methylation and chromatin workflows. It supports high-throughput profiling and is well-suited for large research programs and translational studies. The installed base of sequencing instruments and established pipelines reinforce routine adoption. Falling cost per run and improving chemistries further strengthen NGS utilization.

The US is expected to be the fastest-growing region in the North America epigenetics market during the forecast period.

By country, the North America epigenetics market is divided into the US and Canada. The US holds the largest share and is growing at the fastest rate, supported by a concentrated biopharma base and a strong academic research footprint. It has deeper sequencing infrastructure and broader access to specialized bioinformatics capabilities. Faster clinical translation in oncology and liquid biopsy programs is also driving incremental demand. Strong funding flows and active partnerships across labs and industry sustain its growth momentum.

Key companies active in the North America epigenetics market include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Illumina, Inc. (US), PacBio (US), along with other regional and global companies.

Don’t miss out on business opportunities in North America Epigenetics Market . Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/